Published in Allergy Asthma Proc on February 11, 2013
Non- and semi-invasive methods of monitoring eosinophilic esophagitis. Dig Dis (2014) 0.79
Prospective assessment of serum periostin as a biomarker for diagnosis and monitoring of eosinophilic oesophagitis. Aliment Pharmacol Ther (2016) 0.77
Associations of Exhaled Carbon Monoxide and Fractional Exhaled Nitric Oxide with Metabolic Syndrome: A Cohort Study. Sci Rep (2016) 0.75
Eosinophilic esophagitis: search for noninvasive techniques for long-term monitoring. Gastrointest Endosc (2016) 0.75
Accuracy and Safety of the Cytosponge for Assessing Histologic Activity in Eosinophilic Esophagitis: A Two-Center Study. Am J Gastroenterol (2017) 0.75
Eosinophilic esophagitis: updated consensus recommendations for children and adults. J Allergy Clin Immunol (2011) 12.48
Use of exhaled nitric oxide measurements to guide treatment in chronic asthma. N Engl J Med (2005) 6.96
An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications. Am J Respir Crit Care Med (2011) 5.53
Eosinophilic esophagitis in adults: clinical, endoscopic, histologic findings, and response to treatment with fluticasone propionate. Gastrointest Endosc (2006) 3.65
Increased amount of nitric oxide in exhaled air of asthmatics. Eur Respir J (1993) 3.29
Endogenous nitric oxide is present in the exhaled air of rabbits, guinea pigs and humans. Biochem Biophys Res Commun (1991) 2.79
Height, age, and atopy are associated with fraction of exhaled nitric oxide in a large adult general population sample. Chest (2006) 2.26
Oral viscous budesonide: a potential new therapy for eosinophilic esophagitis in children. Am J Gastroenterol (2007) 1.73
Primarily nasal origin of exhaled nitric oxide and absence in Kartagener's syndrome. Eur Respir J (1994) 1.69
Nitric oxide in inflammatory bowel disease. Inflamm Bowel Dis (2003) 1.68
Atopic disease and exhaled nitric oxide in an unselected population of young adults. Ann Allergy Asthma Immunol (2008) 1.52
Influence of atopy and asthma on exhaled nitric oxide in an unselected birth cohort study. Thorax (2010) 1.37
Increased nitric oxide production and inducible nitric oxide synthase activity in colonic mucosa of patients with active ulcerative colitis and Crohn's disease. Dig Dis Sci (1997) 1.33
Tailored interventions based on exhaled nitric oxide versus clinical symptoms for asthma in children and adults. Cochrane Database Syst Rev (2009) 1.20
Serum nitrate levels in ulcerative colitis and Crohn's disease. Scand J Gastroenterol (1995) 0.99
Are serum concentrations of nitric oxide metabolites useful for predicting the clinical outcome of severe ulcerative colitis? Eur J Gastroenterol Hepatol (1995) 0.92
Inducible nitric oxide synthase activity in colon biopsies from inflammatory areas: correlation with inflammation intensity in patients with ulcerative colitis but not with Crohn's disease. Amino Acids (2000) 0.88
Fractional exhaled nitric oxide in relation to asthma, allergic rhinitis, and atopic dermatitis in Chinese children. J Asthma (2011) 0.87
Rectal nitric oxide assessment in children with Crohn disease and ulcerative colitis. Indicator of ileocaecal and colorectal affection. Scand J Gastroenterol (2001) 0.86
Direct determination of colonic nitric oxide level--a sensitive marker of disease activity in ulcerative colitis. Am J Gastroenterol (1998) 0.86
Exhaled nitric oxide monitoring does not reduce exacerbation frequency or inhaled corticosteroid dose in paediatric asthma: a randomised controlled trial. Clin Respir J (2013) 0.84
Activity related increase of exhaled nitric oxide in Crohn's disease and ulcerative colitis: a manifestation of systemic involvement? Respir Med (2002) 0.84
Exhaled nitric oxide: interactions between asthma, hayfever, and atopic dermatitis in school children. Pediatr Pulmonol (2007) 0.82
The usefulness of biomarkers of airway inflammation in managing asthma. Allergy Asthma Proc (2010) 0.82
Exhaled nitric oxide and nitric oxide synthase expression in Hodgkin's disease. Int J Immunopathol Pharmacol (2010) 0.82
Increased urinary nitrite, a marker of nitric oxide, in active inflammatory bowel disease. Mediators Inflamm (2001) 0.82
Calcium-independent and steroid-resistant nitric oxide synthase activity in human paranasal sinus mucosa. Eur Respir J (1996) 0.81
Exhaled nitric oxide as a tool in managing and monitoring difficult-to-treat asthma. Allergy Asthma Proc (2011) 0.81
Expression of inducible and endothelial nitric oxide synthases in pouchitis. Inflamm Bowel Dis (2001) 0.77
Eosinophilic esophagitis: updated consensus recommendations for children and adults. J Allergy Clin Immunol (2011) 12.48
Trichuris suis therapy for active ulcerative colitis: a randomized controlled trial. Gastroenterology (2005) 5.26
Trichuris suis seems to be safe and possibly effective in the treatment of inflammatory bowel disease. Am J Gastroenterol (2003) 3.40
Short-term treatment with proton-pump inhibitors as a test for gastroesophageal reflux disease: a meta-analysis of diagnostic test characteristics. Ann Intern Med (2004) 2.67
Exposure to schistosome eggs protects mice from TNBS-induced colitis. Am J Physiol Gastrointest Liver Physiol (2002) 2.28
Rapid development of colitis in NSAID-treated IL-10-deficient mice. Gastroenterology (2002) 2.27
Variation in prevalence, diagnostic criteria, and initial management options for eosinophilic gastrointestinal diseases in the United States. J Pediatr Gastroenterol Nutr (2011) 1.96
Heligmosomoides polygyrus inhibits established colitis in IL-10-deficient mice. Eur J Immunol (2004) 1.92
Mechanisms of disease: the hygiene hypothesis revisited. Nat Clin Pract Gastroenterol Hepatol (2006) 1.89
Alteration of the murine gut microbiota during infection with the parasitic helminth Heligmosomoides polygyrus. Inflamm Bowel Dis (2010) 1.85
Granulomas in schistosome and mycobacterial infections: a model of local immune responses. Trends Immunol (2003) 1.75
Intestinal helminths protect in a murine model of asthma. J Immunol (2006) 1.64
Helminths as governors of immune-mediated inflammation. Int J Parasitol (2006) 1.59
Helminth-host immunological interactions: prevention and control of immune-mediated diseases. Ann N Y Acad Sci (2012) 1.47
Proton pump inhibitor use and the risk of small intestinal bacterial overgrowth: a meta-analysis. Clin Gastroenterol Hepatol (2012) 1.47
Long-term remission of nondysplastic Barrett's esophagus after multipolar electrocoagulation ablation: report of 139 patients with 10 years of follow-up. Gastrointest Endosc (2010) 1.42
Hereditary nonpolyposis colorectal cancer: diagnostic strategies and their implications. Evid Rep Technol Assess (Full Rep) (2007) 1.42
Colonization with Heligmosomoides polygyrus suppresses mucosal IL-17 production. J Immunol (2008) 1.35
Heligmosomoides polygyrus promotes regulatory T-cell cytokine production in the murine normal distal intestine. Infect Immun (2007) 1.35
Induction of CD8+ regulatory T cells in the intestine by Heligmosomoides polygyrus infection. Am J Physiol Gastrointest Liver Physiol (2006) 1.28
Differential regulation of CCL21 in lymphoid/nonlymphoid tissues for effectively attracting T cells to peripheral tissues. J Clin Invest (2003) 1.27
Concomitant BRAF and PI3K/mTOR blockade is required for effective treatment of BRAF(V600E) colorectal cancer. Clin Cancer Res (2013) 1.21
Treatment of Helicobacter gastritis with IL-4 requires somatostatin. Proc Natl Acad Sci U S A (2003) 1.19
Therapeutic potential of helminth soluble proteins in TNBS-induced colitis in mice. Inflamm Bowel Dis (2009) 1.17
Heligmosomoides polygyrus bakeri induces tolerogenic dendritic cells that block colitis and prevent antigen-specific gut T cell responses. J Immunol (2012) 1.17
Heligmosomoides polygyrus induces TLR4 on murine mucosal T cells that produce TGFbeta after lipopolysaccharide stimulation. J Immunol (2006) 1.15
Role of T cell TGF-beta signaling in intestinal cytokine responses and helminthic immune modulation. Eur J Immunol (2009) 1.12
Anti-interferon-inducible chemokine, CXCL10, reduces colitis by impairing T helper-1 induction and recruitment in mice. Inflamm Bowel Dis (2005) 1.11
Fas-positive T cells regulate the resolution of airway inflammation in a murine model of asthma. J Exp Med (2006) 1.10
Signaling through Fc gamma RIII is required for optimal T helper type (Th)2 responses and Th2-mediated airway inflammation. J Exp Med (2007) 1.09
Heligmosomoides polygyrus infection can inhibit colitis through direct interaction with innate immunity. J Immunol (2010) 1.09
Working with the US Food and Drug Administration: progress and timelines in understanding and treating patients with eosinophilic esophagitis. J Allergy Clin Immunol (2012) 1.02
Coinfection with the intestinal nematode Heligmosomoides polygyrus markedly reduces hepatic egg-induced immunopathology and proinflammatory cytokines in mouse models of severe schistosomiasis. Infect Immun (2008) 1.02
Heligmosomoides polygyrus bakeri infection activates colonic Foxp3+ T cells enhancing their capacity to prevent colitis. J Immunol (2013) 0.97
Where are we on worms? Curr Opin Gastroenterol (2012) 0.96
Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease. Cochrane Database Syst Rev (2013) 0.96
Emergency management of pediatric convulsive status epilepticus: a multicenter study of 542 patients. Pediatr Emerg Care (2009) 0.95
Helminths and the modulation of mucosal inflammation. Curr Opin Gastroenterol (2005) 0.94
Established T(H1) granulomatous responses induced by active Mycobacterium avium infection switch to T(H2) following challenge with Schistosoma mansoni. Clin Immunol (2002) 0.93
CD4+ T cells from IL-10-deficient mice transfer susceptibility to NSAID-induced Rag colitis. Am J Physiol Gastrointest Liver Physiol (2004) 0.91
Helminthic therapy: using worms to treat immune-mediated disease. Adv Exp Med Biol (2009) 0.91
Cutting edge: hemokinin has substance P-like function and expression in inflammation. J Immunol (2004) 0.89
Patterns of presentation to the Australian and New Zealand Paediatric Emergency Research Network. Emerg Med Australas (2009) 0.89
Substance P receptor mediated maintenance of chronic inflammation in EAE. J Neuroimmunol (2006) 0.88
IL-12 induction of mRNA encoding substance P in murine macrophages from the spleen and sites of inflammation. J Immunol (2005) 0.87
TGF-beta regulates T-cell neurokinin-1 receptor internalization and function. Proc Natl Acad Sci U S A (2010) 0.87
Interleukin-4 receptor alpha chain and STAT6 signaling inhibit gamma interferon but not Th2 cytokine expression within schistosome granulomas. Infect Immun (2002) 0.86
CD4+ TCR repertoire heterogeneity in Schistosoma mansoni-induced granulomas. J Immunol (2002) 0.86
ICOS costimulation expands Th2 immunity by augmenting migration of lymphocytes to draining lymph nodes. J Immunol (2008) 0.86
Normalization of plasma glucose concentration by insulin therapy improves insulin-stimulated glycogen synthesis in type 2 diabetes. Diabetes (2002) 0.85
Comparison of 2 delivery vehicles for viscous budesonide to treat eosinophilic esophagitis in children. J Pediatr Gastroenterol Nutr (2014) 0.85
Is there a role for helminths in the therapy of inflammatory bowel disease? Nat Clin Pract Gastroenterol Hepatol (2005) 0.84
Interleukin-12 (IL-12) and IL-23 induction of substance p synthesis in murine T cells and macrophages is subject to IL-10 and transforming growth factor beta regulation. Infect Immun (2008) 0.83
Fas ligand expression on T cells is sufficient to prevent prolonged airway inflammation in a murine model of asthma. Am J Respir Cell Mol Biol (2009) 0.83
Schistosoma mansoni proteins attenuate gastrointestinal motility disturbances during experimental colitis in mice. World J Gastroenterol (2010) 0.83
CD28 and ICOS play complementary non-overlapping roles in the development of Th2 immunity in vivo. Cell Immunol (2009) 0.83
Trichuris suis might be effective in treating allergic rhinitis. J Allergy Clin Immunol (2010) 0.83
Inducible costimulator expression regulates the magnitude of Th2-mediated airway inflammation by regulating the number of Th2 cells. PLoS One (2009) 0.82
T cell substance P receptor governs antigen-elicited IFN-gamma production. Am J Physiol Gastrointest Liver Physiol (2002) 0.82
Effects of fish oil supplementation on kidney transplantation: a systematic review and meta-analysis of randomized, controlled trials. J Am Soc Nephrol (2005) 0.81
Why Trichuris suis should prove safe for use in inflammatory bowel diseases. Inflamm Bowel Dis (2005) 0.81
Substance P expression correlates with severity of diarrhea in cryptosporidiosis. J Infect Dis (2003) 0.81
Reduced CTL response and increased viral burden in substance P receptor-deficient mice infected with murine gamma-herpesvirus 68. J Immunol (2003) 0.81
Emergency management of paediatric status epilepticus in Australia and New Zealand: practice patterns in the context of clinical practice guidelines. J Paediatr Child Health (2009) 0.80
Colchicine or methotrexate, with ursodiol, are effective after 20 years in a subset of patients with primary biliary cirrhosis. Clin Gastroenterol Hepatol (2011) 0.80
Both Pre-Transplant and Early Post-Transplant Antireflux Surgery Prevent Development of Early Allograft Injury After Lung Transplantation. J Gastrointest Surg (2016) 0.78
Therapeutic colonization with Trichuris suis. Arch Pathol Lab Med (2006) 0.78
IL-4 inhibits vasoactive intestinal peptide production by macrophages. Am J Physiol Gastrointest Liver Physiol (2002) 0.78
Laryngopharyngeal reflux and GERD. Ann N Y Acad Sci (2013) 0.77
Paediatric Research in Emergency Departments International Collaborative (PREDICT): first steps towards the development of an Australian and New Zealand research network. Emerg Med Australas (2006) 0.76
Risk of non-melanoma skin cancer in autoimmune hepatitis. Dig Dis Sci (2010) 0.76
Respiratory manifestations of gastroesophageal reflux disease. Ann N Y Acad Sci (2013) 0.76
Methotrexate for treatment of primary biliary cirrhosis. Hepatology (2006) 0.75
Hiccups as a presenting symptom of eosinophilic esophagitis. Case Rep Gastroenterol (2012) 0.75
Innovative techniques in evaluating the esophagus; imaging of esophageal morphology and function; and drugs for esophageal disease. Ann N Y Acad Sci (2013) 0.75